000170193 001__ 170193
000170193 005__ 20240229133707.0
000170193 0247_ $$2doi$$a10.1038/s41388-021-01981-5
000170193 0247_ $$2pmid$$apmid:34376808
000170193 0247_ $$2ISSN$$a0950-9232
000170193 0247_ $$2ISSN$$a1476-5594
000170193 0247_ $$2altmetric$$aaltmetric:111948184
000170193 037__ $$aDKFZ-2021-01816
000170193 041__ $$aEnglish
000170193 082__ $$a610
000170193 1001_ $$aMiller, Anna K$$b0
000170193 245__ $$aOrnithine decarboxylase (ODC1) gene variant (rs2302615) is associated with gastric cancer independently of Helicobacter pylori CagA serostatus.
000170193 260__ $$aLondon$$bSpringer Nature$$c2021
000170193 3367_ $$2DRIVER$$aarticle
000170193 3367_ $$2DataCite$$aOutput Types/Journal article
000170193 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1642416887_22337
000170193 3367_ $$2BibTeX$$aARTICLE
000170193 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000170193 3367_ $$00$$2EndNote$$aJournal Article
000170193 500__ $$a2021 Oct;40(40):5963-5969
000170193 520__ $$aThe primary cause of gastric cancer is chronic infection with Helicobacter pylori (H. pylori), particularly the high-risk genotype cagA, and risk modification by human genetic variants. We studied 94 variants in 54 genes for association with gastric cancer, including rs2302615 in ornithine decarboxylase (ODC1), which may affect response to chemoprevention with the ODC inhibitor, eflornithine (difluoromethylornithine; DFMO). Our population-based, case-control study included 1366 individuals (664 gastric cancer cases and 702 controls) from Western Honduras, a high incidence region of Latin America. CagA seropositivity was strongly associated with cancer (OR = 3.6; 95% CI: 2.6, 5.1). The ODC1 variant rs2302615 was associated with gastric cancer (OR = 1.36; p = 0.018) in a model adjusted for age, sex, and CagA serostatus. Two additional single nucleotide polymorphisms (SNPs) in CASP1 (rs530537) and TLR4 (rs1927914) genes were also associated with gastric cancer in univariate models as well as models adjusted for age, sex, and CagA serostatus. The ODC1 SNP association with gastric cancer was stronger in individuals who carried the TT genotype at the associating TLR4 polymorphism, rs1927914 (OR = 1.77; p = 1.85 × 10-3). In conclusion, the ODC1 variant, rs2302615, is associated with gastric cancer and supports chemoprevention trials with DFMO, particularly in individuals homozygous for the T allele at rs1927914.
000170193 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000170193 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000170193 7001_ $$00000-0003-1453-4348$$aTavera, Gloria$$b1
000170193 7001_ $$aDominguez, Ricardo L$$b2
000170193 7001_ $$aCamargo, M Constanza$$b3
000170193 7001_ $$0P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30$$aWaterboer, Tim$$b4$$udkfz
000170193 7001_ $$00000-0003-4421-1830$$aWilson, Keith T$$b5
000170193 7001_ $$00000-0002-4835-9544$$aWilliams, Scott M$$b6
000170193 7001_ $$00000-0002-1136-0963$$aMorgan, Douglas R$$b7
000170193 773__ $$0PERI:(DE-600)2008404-3$$a10.1038/s41388-021-01981-5$$n40$$p5963-5969$$tOncogene$$v40$$x1476-5594$$y2021
000170193 909CO $$ooai:inrepo02.dkfz.de:170193$$pVDB
000170193 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000170193 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000170193 9141_ $$y2021
000170193 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONCOGENE : 2019$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-27
000170193 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bONCOGENE : 2019$$d2021-01-27
000170193 9201_ $$0I:(DE-He78)F022-20160331$$kF022$$lInfektionen und Krebs-Epidemiologie$$x0
000170193 9201_ $$0I:(DE-He78)F020-20160331$$kF020$$lInfektionen und Krebs-Epidemiologie$$x1
000170193 980__ $$ajournal
000170193 980__ $$aVDB
000170193 980__ $$aI:(DE-He78)F022-20160331
000170193 980__ $$aI:(DE-He78)F020-20160331
000170193 980__ $$aUNRESTRICTED